Calculation of Melanoma Mitotic Rate Standardized on Whole Slide Images
|
By LabMedica International staff writers Posted on 19 Oct 2021 |

Image: Mitotic Rate and Melanoma Diagnosis: The higher the mitotic count (circled), the more likely the tumor is to have metastasized (Photo courtesy of Arlen Ramsey)
Mitotic rate is an important factor with prognostic relevance in melanoma as well as in other neoplasms. Higher mitotic activity correlates significantly with reduced survival, and is an important parameter in prognostic models offering tailored predictions of prognosis for individual patients with melanoma.
However, accurate mitotic figure counting on hematoxylin-eosin–stained sections can be labor-intensive and challenging. Ideally, the area of the lesion containing the most mitotic figures (the “hot spot”) is identified, and then the mitotic rate is calculated in a 1-mm2 region encompassing the hot spot. The recent availability of digital whole slide image (WSI) data sets from glass slides creates new opportunities for computer-aided diagnostic technologies.
Pathologists at the University of Texas MD Anderson Cancer Center (Houston, TX, USA) established a standardized method to enclose a 1-mm2 region of interest for mitotic figure (MF) counting in melanoma based on WSIs and assess the method's effectiveness. They retrospectively searched their institutional pathology database and chose 30 melanoma cases with reported mitotic figures ranging from 0 to 28. The WSIs for these 30 melanoma cases were created by digitally scanning the original H&E-stained glass slides at ×20 magnification with a ScanScope digital pathology system (Aperio, Vista, CA, USA) with SVS format.
Mitotic figures were defined as the unequivocal presence of extensions of chromatin (condensed chromosomes) extending from a condensed chromatin mass, corresponding to either a metaphase or telophase figure. For each WSI, the mitotic rate was evaluated by first finding the hot spot (i.e., the region of the lesion containing the most mitotic figures) and then counting mitotic figures beginning in the hot spot and then extending to the immediately adjacent non-overlapping viewing fields until an area of tissue corresponding to 1 mm2 was assessed. Fixed-shape annotations with 500 × 500-μm squares or circles were applied depending on the specimen orientation during mitotic figure counting, because this approach is able to achieve convenient annotation and efficient counting while ensuring easy transition from traditional glass slides.
The scientists reported that of the monitors they examined, a 32-inch monitor with 3840 × 2160 resolution was optimal for counting MFs within a 1-mm2 region of interest in melanoma. When WSIs were viewed in the ImageScope viewer, ×10 to ×20 magnification during screening could efficiently locate a hot spot and ×20 to ×40 magnification during counting could accurately identify MFs. Fixed-shape annotations with 500 × 500-μm squares or circles can precisely and efficiently enclose a 1-mm2 region of interest. Their method on WSIs was able to produce a higher mitotic rate than with glass slides.
The authors concluded that mitotic figure counting in melanoma using WSIs is equivalent to using glass slides and can be efficiently done in real practice. In terms of annotation methodology, they recommended fixed-shape annotations with 4 squares or 5 circles in a setting of 500 × 500 μm to cover a 1-mm2 region. The pathologist can easily enclose the region of interest of the tumor and effectively match up irregular tumor regions with position adjustments of the four squares or five circles. If the tumor has a large contiguous area, a single-square annotation of 1000 × 1000 μm can be used. Their methodology can be potentially extended to calculating mitotic rate in other tumors. The study was published in the October, 2021 issue of the journal Archives of Pathology and Laboratory Medicine.
Related Links:
University of Texas MD Anderson Cancer Center
Aperio
However, accurate mitotic figure counting on hematoxylin-eosin–stained sections can be labor-intensive and challenging. Ideally, the area of the lesion containing the most mitotic figures (the “hot spot”) is identified, and then the mitotic rate is calculated in a 1-mm2 region encompassing the hot spot. The recent availability of digital whole slide image (WSI) data sets from glass slides creates new opportunities for computer-aided diagnostic technologies.
Pathologists at the University of Texas MD Anderson Cancer Center (Houston, TX, USA) established a standardized method to enclose a 1-mm2 region of interest for mitotic figure (MF) counting in melanoma based on WSIs and assess the method's effectiveness. They retrospectively searched their institutional pathology database and chose 30 melanoma cases with reported mitotic figures ranging from 0 to 28. The WSIs for these 30 melanoma cases were created by digitally scanning the original H&E-stained glass slides at ×20 magnification with a ScanScope digital pathology system (Aperio, Vista, CA, USA) with SVS format.
Mitotic figures were defined as the unequivocal presence of extensions of chromatin (condensed chromosomes) extending from a condensed chromatin mass, corresponding to either a metaphase or telophase figure. For each WSI, the mitotic rate was evaluated by first finding the hot spot (i.e., the region of the lesion containing the most mitotic figures) and then counting mitotic figures beginning in the hot spot and then extending to the immediately adjacent non-overlapping viewing fields until an area of tissue corresponding to 1 mm2 was assessed. Fixed-shape annotations with 500 × 500-μm squares or circles were applied depending on the specimen orientation during mitotic figure counting, because this approach is able to achieve convenient annotation and efficient counting while ensuring easy transition from traditional glass slides.
The scientists reported that of the monitors they examined, a 32-inch monitor with 3840 × 2160 resolution was optimal for counting MFs within a 1-mm2 region of interest in melanoma. When WSIs were viewed in the ImageScope viewer, ×10 to ×20 magnification during screening could efficiently locate a hot spot and ×20 to ×40 magnification during counting could accurately identify MFs. Fixed-shape annotations with 500 × 500-μm squares or circles can precisely and efficiently enclose a 1-mm2 region of interest. Their method on WSIs was able to produce a higher mitotic rate than with glass slides.
The authors concluded that mitotic figure counting in melanoma using WSIs is equivalent to using glass slides and can be efficiently done in real practice. In terms of annotation methodology, they recommended fixed-shape annotations with 4 squares or 5 circles in a setting of 500 × 500 μm to cover a 1-mm2 region. The pathologist can easily enclose the region of interest of the tumor and effectively match up irregular tumor regions with position adjustments of the four squares or five circles. If the tumor has a large contiguous area, a single-square annotation of 1000 × 1000 μm can be used. Their methodology can be potentially extended to calculating mitotic rate in other tumors. The study was published in the October, 2021 issue of the journal Archives of Pathology and Laboratory Medicine.
Related Links:
University of Texas MD Anderson Cancer Center
Aperio
Latest Pathology News
- Uncertainty-Aware AI Platform Supports Automated HER2 Assessment in Breast Cancer
- AI Tool Speeds Brain Tumor Classification from Routine Histology Slides
- IHC Companion Diagnostic Standardizes Mismatch Repair Testing for Cancer Immunotherapy
- AI Pathology Tool Predicts Meningioma Recurrence from Routine Slides
- 3D Spatial Multi-Omics Maps Intra-Tumor Diversity in Colorectal Cancer
- Blood-Based Method Tracks Gene Activity in the Living Brain
- FDA Approval Expands Automated PD-L1 Testing Across Solid Tumors
- AI-Powered Atlas Maps Immune Structures Linked to Cancer Outcomes
- AI Tool Extracts Immune Signals from Biopsy to Inform Myeloma Therapy
- Rapid AI Tool Predicts Cancer Spatial Gene Expression from Pathology Images
- AI Pathology Test Receives FDA Breakthrough for Bladder Cancer Risk Stratification
- FDA Clears AI Digital Pathology Tool for Breast Cancer Risk Stratification
- New AI Tool Reveals Hidden Genetic Signals in Routine H&E Slides
- AI System Analyzes Routine Pathology Slides to Predict Cancer Outcomes
- New Tissue Mapping Approach Identifies High-Risk Form of Diabetic Kidney Disease
- Multimodal AI Tool Predicts Genetic Alterations to Guide Breast Cancer Treatment
Channels
Clinical Chemistry
view channel
Simple Blood-Based Cholesterol Efflux Assay Identifies High-Risk Coronary Plaque Features
Unstable coronary plaques are difficult to identify before they trigger acute cardiovascular events. Standard high-density lipoprotein (HDL) measurements do not always capture how well HDL particles function... Read more
Plasma Vitamin C Levels Associated with Brain Structure and Connectivity in Aging
Previous studies have linked vitamin C–rich diets with lower risk of cognitive impairment in older adults. However, few investigations have directly examined blood plasma vitamin C in relation to brain... Read more
Mass Spectrometry Detects Tumor Metabolites for Cancer Monitoring
Cancer’s altered metabolism complicates how clinicians detect and monitor tumors, because nutrient use can shift with context and time. Measuring small-molecule metabolites that distinguish malignant from... Read more
Urinary Biomarker Assay Predicts Kidney Disease Progression Beyond Standard Measures
Many patients with type 2 diabetes and chronic kidney disease continue to experience progressive renal decline, yet conventional markers such as albuminuria and estimated glomerular filtration rate (eGFR)... Read moreMolecular Diagnostics
view channel
Ultrasensitive HPV Blood Test Predicts Early Recurrence in Head and Neck Cancer
Human papillomavirus (HPV)-associated head and neck cancers are frequently treated with surgery, but some patients experience recurrence due to residual microscopic disease. Postoperative decisions about... Read more
New Library Normalization and Amplification Tools Support Oncology Sequencing
High-throughput next-generation sequencing (NGS) laboratories continue to grapple with uneven library pooling and amplification artifacts that can degrade variant calling accuracy and increase reruns.... Read moreHematology
view channel
Next-Generation Hematology Platform Streamlines High-Complexity Lab Workflows
Sysmex America (Chicago, IL, USA) has introduced the next generation XR-Series, centered on the XR-10 Automated Hematology Module for high-complexity laboratories. The platform builds on the widely used... Read more
Blood Eosinophil Count May Predict Cancer Immunotherapy Response and Toxicity
Immune checkpoint inhibitors have improved outcomes across many cancers, yet only a subset of patients derive durable benefit and biomarkers to guide treatment remain limited. Eosinophils, best known for... Read moreImmunology
view channelAptamer-Based Biosensor Enables Mutation-Resilient SARS-CoV-2 Detection
Rapid evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can undermine existing molecular diagnostics, especially when assays target small viral components. Double-antibody sandwich... Read more
Study Points to Autoimmune Pathway Behind Long COVID Symptoms
Long COVID leaves many SARS-CoV-2 survivors with persistent fatigue, cognitive issues, palpitations, and musculoskeletal pain for months or years. Estimates cited in new research suggest 4%–20% of infected... Read more
Metabolic Biomarker Distinguishes Latent from Active Tuberculosis and Tracks Treatment Response
Tuberculosis (TB) remains the world’s leading infectious killer, with 10.8 million cases and 1.25 million deaths recorded globally in 2023. Yet many infected individuals never develop active disease, underscoring... Read moreMicrobiology
view channel
TORCH Infection Trends Point to Need for Tailored Screening in Pregnancy
Congenital TORCH infections can be asymptomatic during pregnancy yet cause stillbirth, birth defects, and lifelong disability in infants. Many regions still lack robust surveillance to guide testing and... Read more
New Culture Medium Speeds C. difficile Resistance Detection and Reduces Costs
Clostridioides difficile infections remain a persistent threat in hospitals and communities, affecting about 500,000 people in the United States each year. Severe cases can be fatal within 30 days of diagnosis,... Read moreTechnology
view channel
AI Platform Links Biomarker Results to Cancer Clinical Trials and Guidelines
Oncology teams must manage growing volumes of genomic data, rapidly evolving clinical trial options, and frequently updated care guidelines, all within tight clinic schedules. Translating complex tumor... Read more
Agentic AI Platform Supports Genomic Decision-Making in Oncology
Oncology care teams increasingly face the challenge of managing complex molecular diagnostics, evolving treatment options, and extensive electronic health record documentation. Translating multimodal data... Read moreIndustry
view channel
Open-Source Consortium Aims to Standardize Digital Pathology Workflows
Digital pathology is expanding rapidly as laboratories adopt whole-slide imaging and computational tools to meet growing diagnostic and biomarker-testing demand. However, fragmented software infrastructure... Read more








